SCHEMBL5919954

SCHEMBL5919954

CCCCCc1ccc(OC(=O)O)c(O)c1CC[Si](C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 4/20 0.38
▸ PPARG P37231 3/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ALOX5 P09917 2/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ TYR P14679 1/20 0.37
▸ BID P55957 3/20 0.36
▸ MCL1 Q07820 3/20 0.36
▸ BCL2L1 Q07817 2/20 0.36
▸ BAK1 Q16611 2/20 0.36
▸ KAT8 Q9H7Z6 2/20 0.36
▸ EP300 Q09472 1/20 0.36
▸ KAT2A Q92830 1/20 0.36
▸ KAT2B Q92831 1/20 0.36
▸ KAT5 Q92993 1/20 0.36
▸ SAE1 Q9UBE0 1/20 0.36
▸ THRA P10827 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ PPARD Q03181 1/20 0.36
▸ TLR8 Q9NR97 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588176 0.90 TYR (0.45) PPARAPPARGTSHRALOX5PTGS2
SCHEMBL5681229 0.88 FFAR4 (0.31) TSHR
SCHEMBL5590459 0.88 TYR (0.48) PPARAPPARGTSHRALOX5PTGS2
SCHEMBL5589011 0.88 TYR (0.48) PPARAPPARGTSHRALOX5PTGS2
SCHEMBL5589532 0.88 TYR (0.48) PPARAPPARGTSHRALOX5PTGS2
SCHEMBL5677027 0.88 ALOX5 (0.42) PPARAPPARGTSHRALOX5PTGS2
SCHEMBL5586630 0.88 TYR (0.48) PPARAPPARGTSHRALOX5PTGS2
SCHEMBL5588746 0.88 TYR (0.48) PPARAPPARGTSHRALOX5PTGS2
SCHEMBL5195274 0.88 TYR (0.44) PPARAPPARGTSHRALOX5PTGS2
SCHEMBL5677872 0.88 TYR (0.44) PPARAPPARGTSHRALOX5PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR PPARA 3398/4885PPARG 3732/4885TSHR 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback